D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Amazon
AMZN
|
+$490M |
| 2 |
Microsoft
MSFT
|
+$461M |
| 3 |
Estee Lauder
EL
|
+$422M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$239M |
| 5 |
Nike
NKE
|
+$234M |
Top Sells
| 1 |
Walmart
WMT
|
+$585M |
| 2 |
Tesla
TSLA
|
+$470M |
| 3 |
NVIDIA
NVDA
|
+$431M |
| 4 |
Eli Lilly
LLY
|
+$360M |
| 5 |
T-Mobile US
TMUS
|
+$299M |
Sector Composition
| 1 | Technology | 26.44% |
| 2 | Consumer Discretionary | 14.71% |
| 3 | Healthcare | 12.37% |
| 4 | Financials | 8.93% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Novavax
NVAX
$1.36B
| $113K | ﹤0.01% |
+15,597
| New | +$113K |
|
2527
Pearson
PSO
$9.04B
| $112K | ﹤0.01% |
10,598
-5,800
| -35% | -$61.1K |
|
2528
American Axle
AXL
$743M
| $110K | ﹤0.01% |
15,200
-18,867
| -55% | -$137K |
|
|
DNMR
2529
DELISTED
Danimer Scientific, Inc.
DNMR
| $109K | ﹤0.01% |
1,317
| – | – |
|
|
PRPC
2530
DELISTED
CC Neuberger Principal Holdings III
PRPC
| $109K | ﹤0.01% |
10,000
| – | – |
|
|
PNNT
2531
Pennant Park Investment Corp
PNNT
$444M
| $109K | ﹤0.01% |
16,547
-29,818
| -64% | -$196K |
|
2532
Actinium Pharmaceuticals
ATNM
$50.2M
| $107K | ﹤0.01% |
18,002
-10,752
| -37% | -$63.7K |
|
|
SOC.WS
2533
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
| $105K | ﹤0.01% |
131,297
| – | – |
|
2534
ChargePoint
CHPT
$245M
| $104K | ﹤0.01% |
+1,051
| New | +$104K |
|
2535
Nerdy
NRDY
$154M
| $102K | ﹤0.01% |
27,675
-97,347
| -78% | -$360K |
|
|
AMRN
2536
Amarin Corp
AMRN
$302M
| $101K | ﹤0.01% |
5,516
-5,697
| -51% | -$105K |
|
2537
Pure Cycle
PCYO
$269M
| $98K | ﹤0.01% |
10,210
-103
| -1% | -$989 |
|
2538
ESS Tech
GWH
$22.9M
| $97.3K | ﹤0.01% |
+3,449
| New | +$97.3K |
|
2539
CytomX Therapeutics
CTMX
$323M
| $94.8K | ﹤0.01% |
73,494
-56,966
| -44% | -$73.5K |
|
2540
Generation Bio
GBIO
$40.1M
| $94.7K | ﹤0.01% |
2,499
-1,125
| -31% | -$42.6K |
|
2541
Acacia Research
ACTG
$319M
| $94.4K | ﹤0.01% |
25,852
-33,841
| -57% | -$124K |
|
2542
Talkspace, Inc. Warrant
TALKW
$2.73M
| $94.1K | ﹤0.01% |
817,475
+678,869
| +490% | +$78.1K |
|
2543
Garrett Motion
GTX
$2.62B
| $93.4K | ﹤0.01% |
+11,853
| New | +$93.4K |
|
2544
Rumble
RUM
$2.55B
| $93K | ﹤0.01% |
18,239
-7,103
| -28% | -$36.2K |
|
|
MRNS
2545
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $91.8K | ﹤0.01% |
11,400
-343,348
| -97% | -$2.76M |
|
2546
Polestar Automotive Holding ADS Class C-1
PSNYW
$653M
| $91.5K | ﹤0.01% |
230,468
| – | – |
|
2547
Nuvation Bio
NUVB
$1.12B
| $91.1K | ﹤0.01% |
67,971
-44,265
| -39% | -$59.3K |
|
|
BHR
2548
Braemar Hotels & Resorts
BHR
$203M
| $90.7K | ﹤0.01% |
+32,727
| New | +$90.7K |
|
2549
American Well
AMWL
$105M
| $89.9K | ﹤0.01% |
3,841
+916
| +31% | +$21.4K |
|
2550
UWM Holdings
UWMC
$1.45B
| $89.3K | ﹤0.01% |
18,419
-18,586
| -50% | -$90.1K |
|